415 related articles for article (PubMed ID: 24654688)
1. Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data.
Wong RJ; Chou C; Bonham CA; Concepcion W; Esquivel CO; Ahmed A
Clin Transplant; 2014 Jun; 28(6):713-21. PubMed ID: 24654688
[TBL] [Abstract][Full Text] [Related]
2. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
Wong RJ; Ahmed A
Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
4. Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation.
Cheong J; Galanko JA; Arora S; Cabezas J; Ndugga NJ; Lucey MR; Hayashi PH; Barritt AS; Bataller R
Liver Int; 2017 Feb; 37(2):290-298. PubMed ID: 27258535
[TBL] [Abstract][Full Text] [Related]
5. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
6. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
7. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
[TBL] [Abstract][Full Text] [Related]
10. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
11. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
Nagai S; Collins K; Chau LC; Safwan M; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2759-2768.e5. PubMed ID: 31004758
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
[TBL] [Abstract][Full Text] [Related]
13. Impact of body mass index in liver transplantation for nonalcoholic fatty liver disease and alcoholic liver disease.
O'Neill S; Napetti S; Cornateanu S; Sutherland AI; Wigmore S; Oniscu GC; Adair A
HPB (Oxford); 2017 Dec; 19(12):1074-1081. PubMed ID: 28888774
[TBL] [Abstract][Full Text] [Related]
14. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
Hassan I; Gane E
Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
[TBL] [Abstract][Full Text] [Related]
15. Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
McCabe P; Galoosian A; Wong RJ
Dig Dis Sci; 2020 May; 65(5):1501-1511. PubMed ID: 31642005
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database.
Singal AK; Bashar H; Anand BS; Jampana SC; Singal V; Kuo YF
Hepatology; 2012 May; 55(5):1398-405. PubMed ID: 22213344
[TBL] [Abstract][Full Text] [Related]
17. Negative outcomes after liver transplantation in patients with alcoholic liver disease beyond the fifth post-transplant year.
Grąt M; Lewandowski Z; Grąt K; Wronka KM; Krasnodębski M; Barski K; Zborowska H; Patkowski W; Zieniewicz K; Krawczyk M
Clin Transplant; 2014 Oct; 28(10):1112-20. PubMed ID: 25059535
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
Wong RJ; Aguilar M; Cheung R; Perumpail RB; Harrison SA; Younossi ZM; Ahmed A
Gastroenterology; 2015 Mar; 148(3):547-55. PubMed ID: 25461851
[TBL] [Abstract][Full Text] [Related]
20. Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology.
Singal AK; Salameh H; Kuo YF; Wiesner RH
Transplantation; 2014 Jul; 98(2):216-21. PubMed ID: 24621538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
